Does walking improve cardiometabolic health but need resistance or higher-intensity exercise to build muscle and optimize glucose disposal?

Regular walking is a cornerstone of cardiovascular health, but optimizing muscle mass and metabolic function in older adults requires a more robust stimulus to overcome age-related anabolic resistance.

Clinical and cardiometabolic evidence

• Cardiovascular protection: Habitual walking is associated with a 30% to 40% reduction in cardiovascular disease (CVD) events and mortality. Walking interventions consistently lower systolic blood pressure by 3 to 4 mmHg and diastolic blood pressure by 1.5 to 2 mmHg.
• Hypertrophy and metabolic limitations: Walking alone does not induce measurable gains in skeletal muscle mass or cross-sectional area. Relying solely on low-intensity walking also yields less robust and more transient improvements in peripheral glucose disposal compared to higher-intensity modalities.

Mechanistic pathways

• Muscle protein synthesis: Progressive resistance training provides the mechanical tension necessary to robustly activate the intracellular mTORC1 signaling pathway. This triggers an elevation in myofibrillar protein synthesis that persists for 24 to 48 hours, driving hypertrophic remodeling.
• Glucose disposal machinery: High-intensity interval training (HIIT) and resistance training act as potent triggers for GLUT4 expression and translocation to the sarcolemma via AMPK and AS160 pathways. Furthermore, resistance training expands skeletal muscle mass, providing a larger physical sink for glucose disposal while enhancing microvascular blood perfusion.

Bottom line

• While walking is highly effective for blood pressure control and reducing cardiovascular mortality, incorporating progressive resistance or high-intensity exercise is essential to activate the mTORC1 and GLUT4 pathways required to preserve muscle mass and optimize insulin-sensitive glucose disposal.